Iterum Therapeutics Plc (ITRM) Misses Q3 EPS by 5c

Iterum Therapeutics Plc (NASDAQ: ITRM) reported Q3 EPS of ($0.16), $0.05 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $390 thousand versus the consensus estimate of $0 .

For earnings history and earnings-related data on Iterum Therapeutics Plc (ITRM) click here.

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• BW LPG Limited (BWLP) Reports Q1 EPS of $0.79
• Jiayin Group (JFIN) Reports Q2 Loss of RMB3.56